PCNA and Ki-67 in endometrial hyperplasias and evaluation of the potential of malignancy

European Journal of Gynaecological Oncology

Volumn 32, Issue 1, 2011, Pages 77-80

  Abike, F ^a   Tapisiz, O L ^a   Zergeroglu, S ^a   Dunder, I ^b   Temizkan, I ^a   Payasli, A ^a  

^a ZEKAI TAHIR BURAK WOMEN S HEALTH EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b ISTANBUL BILIM UNIVERSITY   (Turkey)

Author keywords

Endometrial carcinoma; Endometrial hyperplasia; Ki 67; PCNA

Indexed keywords

CYCLINE; FORMALDEHYDE; KI 67 ANTIGEN; PARAFFIN;

ADULT; ARTICLE; CANCER RISK; CONSERVATIVE TREATMENT; CONTROLLED STUDY; CURETTAGE; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOMETRIUM HYPERPLASIA; FEMALE; HUMAN; HUMAN TISSUE; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MOLECULAR PROBE;

ADULT; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MIDDLE AGED; PROLIFERATING CELL NUCLEAR ANTIGEN;

EID: 79952347691     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Wingo P.A., Tong T., Bolden S.: "Cancer Statistics, 1995". C.A. Cancer J. Clin., 1995, 45, 8.
2. Kurman R.J., Kaminski P.F., Norris H.J.: "The behavior of endometrial hyperplasia: a long term study of untreated hyperplasia in 170 patients". Cancer, 1985, 56, 403.
3. Montgomery B.E., Daum G.S., Dunton C.J.: "Endometrial hyperplasia: A Review". Obstet. Gynocol. Surv., 2004, 59, 368.
4. Huang S.J., Ampara E.G., Fu YS.: "Endometrial hyperplasia: Histologic classification and behaviour". Sung. Pathol., 1988, 1, 215.
5. Snider D.D., Stuart G.C., Nation J.G., Robertson D.I.: "Evaluation of surgical staging in stage 1 low malignant potential ovarian tumors". Gynecol. Oncol., 1991, 40, 129.
6. Lewis E., Wallace W.S.: "Radiologic diagnosis of ovarian cancer". In: Piver M.S., (ed.): "Ovarian malignancies". Edinburgh, Churchill Livingstone, 1987, 59.
7. Pickartz H., Beckmann R., Fleige B., Due W., Gerdes J., Stein H.: "Steroid receptors and proliferative activity in non-neoplastic and neoplastic endometria". Virchows Arch. A Pathol. Anat. Histopathol., 1990, 417, 163.
8. Gerdes J., Lemke H., Baisch H., Wacker H.-H., Schwab U., Stein H.: "Cell cycle analysis of a cell proliferation associated human nuclear antigen defined by the monoclonal antibody Ki-67". J. Immunol., 1984, 133, 1710.
9. Keshgegian A.A., Cnaan A.: "Proliferation markers in breast carcinoma. Mitotic figure count, S-phase fraction, proliferating cell nuclear antigen, Ki-67 and MIB-1". Am. J. Clin. Pathol., 1995, 104, 42.
10. Miyachi K., Fritzler M.J., Tan E.M.: "Autoantibody to a nuclear antigen in proliferating cells". J. Immunol., 1978, 121, 2228.
11. Ogata K., Kurki R, Celis J.E., Nakamura R.M., Tan E.M.: "Monoclonal antibodies to a nuclear protein (PCNA/cyclin) associated with DNA replication". Exp. Cell. Res., 1987, 168, 475.
12. Iachino C., Katsikoyiannis N., Dallera F.: "Assessment of proliferating cell nuclear antigen (PCNA) immunoreactivity in exocrine pancreatic carcinomas". Pathologica, 1995, 87, 56.
13. Scott R.J., Hall P.A., Haidane J.S., van Noorden S., Price Y, Lane D.P., Wright N.A.: "A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction". J. Pathol., 1991, 165, 173.
14. Sasano H., Date F., Miyazaki S.: "Correlation of c-myc exspression and cell proliferation in human stomach cancer. A study employing PCNA". Jpn. J. Cancer Res., proceedings of Jpn Cancer Assoc, 1991,129, 704.
15. Sasano H., Watanabe K., Ito K., Sato S., Yajima A.: "New concepts in the diagnosis and prognosis of endometrial carcinoma". Pathol. Annu., 1994, 29, 31.
16. Ito K., Sasano H., Watanabe K., Ozawa N., Sato S., Yajima A.: "Immunohistochemical study of PCNA (proliferating cell nuclear antigen) in normal and abnormal endometrium". Int. J. Gynecol. Cancer, 1993, 3, 122.
17. Yu C.C., Wilkinson N., Brito M.J., Buckley CH., Fox H., Levison D.A.: "Patterns of immunohistochemical staining for proliferating cell nuclear antigen and p53 in benign and neoplastic human endometrium". Histopathology, 1993, 23, 367.
18. Cinel L., Polat A., Aydin O., Düsmez D., Eilmez R.: "Bcl-2, iNOS, p53 and PCNA expression in normal, disordered proliferative, hyperplastic and malignant endometrium". Pathol. Int., 2002, 52, 384.
19. Terlikowski S., Lenczewski A., Famulski W., Sulkowska M., Kulikowski M.: "Proliferative activity in endometrial hyperplasia and adenocarcinoma" . Folia Histochem Cytobiol., 2001, 39, 163.
20. Keshgegian A.A., Cnaan A.: "Proliferation markers in breast carcinoma. Mitotic figure count, S-phase fraction, proliferating cell nuclear antigen, Ki-67 and MIB-1". Am. J. Clin. Pathol., 1995, 104, 42.
21. Weikel W., Brumm C., Wilkens C., Beck T., Knapstein P.G.: "Growth fractions (Ki-67) in primary breast cancers with particular reference to node-negative tumors". Cancer Detect. Prev., 1995, 19, 446.
22. Molino A., Micciolo R., Turazza M., Bonetti R, Piubello Q., Bonetti A. et al.: "GL. Ki-67 immunostaining in 322 primary breast cancers: associations with clinical and pathological variables and prognosis". Int. J. Cancer, 1997, 74, 433.
23. Risberg B., Karlsson K., Abeler V., Lagrelius A., Davidson B., Karlsson M.G.: "Dissociated expression of Bcl-2 and Ki-67 in endometrial lesions: diagnostic and histogenetic implications". Int. J. Gynecol. Pathol., 2002, 21, 155.
24. Ambros R.A.: "Simple hyperplasia of the endometrium: an evaluation of proliferative activity by Ki-67 immunostaning". Int. J. Gynecol. Pathol., 2000, 19, 206.
25. Ioffe O.B., Papadimitriou J.C., Drachenberg C.B.: "Correlation of proliferative indices, apoptosis and related oncogene ekspression (bcl-2 and c-erB-2) and p53 in proliferative, hyperplastic and malignant endometrium". Human. Pathol., 1998, 29, 1150.